About Us

Founded in 2024, Boston Harbor Biotechnologies was established by a team of experts to meet the growing demand for comprehensive services within the cell and gene therapy (CGT) community.



Our mission is to support a broad range of research and development needs, from discovery through process and assay development to IND-enabling and CMC/tech transfer readiness studies. Based in the heart of the Boston bio-hub, we are uniquely positioned to serve both local and global clients.